Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support
- PMID: 22245529
- DOI: 10.1016/j.fertnstert.2011.12.020
Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support
Abstract
Although gonadotropin-releasing hormone agonist (GnRHa) trigger is effective in the prevention of ovarian hyperstimulation syndrome, lower conception rates have been reported. Intensive luteal phase support is an effective approach to improve implantation rates in women with peak E(2) levels ≥ 4,000 pg/mL. However, patients with peak E(2) levels <4,000 pg/mL may require a dual trigger with GnRHa and 1,000 IU hCG and intensive luteal phase support to improve implantation rates.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.Fertil Steril. 2012 Mar;97(3):529-30. doi: 10.1016/j.fertnstert.2011.11.016. Epub 2011 Dec 9. Fertil Steril. 2012. PMID: 22154368
-
Can FSH co-trigger prevent OHSS?Fertil Steril. 2012 Mar;97(3):534-5. doi: 10.1016/j.fertnstert.2012.01.105. Epub 2012 Jan 29. Fertil Steril. 2012. PMID: 22285746
-
Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.Fertil Steril. 2012 Mar;97(3):527-8. doi: 10.1016/j.fertnstert.2011.12.010. Epub 2012 Jan 4. Fertil Steril. 2012. PMID: 22222191
-
Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.Semin Reprod Med. 2010 Nov;28(6):506-12. doi: 10.1055/s-0030-1265678. Epub 2010 Nov 16. Semin Reprod Med. 2010. PMID: 21082510 Review.
-
GnRHa to trigger final oocyte maturation: a time to reconsider.Hum Reprod. 2009 Oct;24(10):2389-94. doi: 10.1093/humrep/dep246. Epub 2009 Jul 16. Hum Reprod. 2009. PMID: 19608565 Review.
Cited by
-
Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles.J Assist Reprod Genet. 2015 Apr;32(4):527-32. doi: 10.1007/s10815-015-0434-1. Epub 2015 Feb 15. J Assist Reprod Genet. 2015. PMID: 25682115 Free PMC article.
-
Gonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series.J Turk Ger Gynecol Assoc. 2015 Mar 1;16(1):35-40. doi: 10.5152/jtgga.2015.15084. eCollection 2015. J Turk Ger Gynecol Assoc. 2015. PMID: 25788848 Free PMC article.
-
Has ART Finally Got a Patient-Friendly Progesterone?J Obstet Gynaecol India. 2015 Oct;65(5):289-92. doi: 10.1007/s13224-015-0731-8. J Obstet Gynaecol India. 2015. PMID: 26405397 Free PMC article. No abstract available.
-
Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition.J Assist Reprod Genet. 2015 Jul;32(7):1063-8. doi: 10.1007/s10815-015-0498-y. Epub 2015 May 17. J Assist Reprod Genet. 2015. PMID: 25982422 Free PMC article.
-
GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.J Assist Reprod Genet. 2017 Nov;34(11):1537-1545. doi: 10.1007/s10815-017-1010-7. Epub 2017 Aug 3. J Assist Reprod Genet. 2017. PMID: 28776117 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources